Shuren: We're Not In Competition With Europe
This article was originally published in The Gray Sheet
Executive Summary
CDRH chief Jeff Shuren says FDA is continuing to reform its regulatory process, especially pointing to the agency's work to shift more data requirements to the postmarket setting, but overall he is confident the US system is close to an "optimal" balance between protecting patients and encouraging innovation.